Sustainable production
Agriculture
Restoring productive and sustainable ecosystems.
Become a shareholder in scientific progress.
“Science has always provided answers to our most fundamental needs. We turn today’s most promising innovations into successful companies that sustainably improve patient care, preserve our environment and strengthen our sovereignty.”Olivier Le Blainvaux, Managing Director
Driven by impact
Sustainable production
Restoring productive and sustainable ecosystems.
Sustainable production
Supplying our industry with sustainable materials.
Healthcare
Improving care while keeping costs under control.
Sovereignty
Strengthening our capabilities to be more resilient.
Sovereignty
Developing frugal and ethical AI.
Sustainable production
Accelerating decarbonisation.
Collaborations with France’s leading research institutes: CNRS, INRAE, CEA…
Cerbair, Ion-X, Les Fermes Debout: successes that embody our ability to bring deeptech champions to life.
Leading institutional investors, family offices and entrepreneurs.
TF Participations II enables visionaries to become shareholders in scientific progress. Discover the fund
Venture partners and operating partners committed day to day to creating and growing deeptech companies.
Investment team

Managing partner
French entrepreneur and co-founder of Technofounders. A graduate of École Polytechnique (2006–2010), he began his career at McKinsey & Company before transitioning to entrepreneurship. He is actively involved in identifying disruptive technologies and structuring investment vehicles to fund innovative projects.
LinkedIn
Managing partner
French entrepreneur and co-founder of Technofounders. A graduate of École Polytechnique, Pierre focuses on creating impactful industrial companies by leveraging existing research projects. Pierre serves as the studio’s president and actively collaborates with major research institutions in France to transform innovative technologies into successful businesses.
LinkedInWhat they say
“Our collaboration with Technofounders made it possible to transfer a promising therapeutic innovation to a medical startup. Their adaptability and their ability to work with the academic world were decisive in making this initiative a reality.”
“Technofounders excellent knowledge of the academic ecosystem and their ability to quickly assess the value-creation potential of technologies that are sometimes still at a very early stage have led to the creation of five high-potential CNRS spin-offs, such as Ion-X in the NewSpace sector and Hiqute Diamond in the strategic field of industrial diamond production.”
FPCI TF Participations II
The fund is reserved for professional or qualified investors. A few questions are all it takes to access its presentation.